This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (241)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

An Overview of Epidemiologic Studies Published in the 1990s

Sonia Hernández-Díaz, MD, MPH; Luis Alberto García Rodríguez, MD, MSc

Arch Intern Med. 2000;160:2093-2099.

Background  In the last decades, studies have estimated the upper gastrointestinal tract bleeding/perforation (UGIB) risk associated with individual nonsteroidal anti-inflammatory drugs (NSAIDs). Later analyses have also included the effect of patterns of NSAID use, risk factors for UGIB, and modifiers of NSAID effect.

Methods  Systematic review of case-control and cohort studies on serious gastrointestinal tract complications and nonaspirin NSAIDs published between 1990 and 1999 using MEDLINE. Eighteen original studies were selected according to predefined criteria. Two researchers extracted the data independently. Pooled relative risk estimates were calculated according to subject and exposure characteristics. Heterogeneity of effects was tested and reasons for heterogeneity were considered.

Results  Advanced age, history of peptic ulcer disease, and being male were risk factors for UGIB. Nonsteroidal anti-inflammatory drug users with advanced age or a history of peptic ulcer had the highest absolute risks. The pooled relative risk of UGIB after exposure to NSAIDs was 3.8 (95% confidence interval, 3.6-4.1). The increased risk was maintained during treatment and returned to baseline once treatment was stopped. A clear dose response was observed. There was some variation in risk between individual NSAIDs, though these differences were markedly attenuated when comparable daily doses were considered.

Conclusions  The elderly and patients with a history of peptic ulcer could benefit the most from a reduction in NSAID gastrotoxicity. Whenever possible, physicians may wish to recommend lower doses to reduce the UGIB risk associated with all individual NSAIDs, especially in the subgroup of patients with the greatest background risk.

From the Department of Epidemiology, Harvard School of Public Health, Boston, Mass (Dr Hernández-Díaz), and the Spanish Center for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain (Dr Garcia Rodríguez).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(14):2228.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK
Suh et al.
Rheumatology (Oxford) 2008;47:458-463.
ABSTRACT | FULL TEXT  

Chronic musculoskeletal conditions and comorbidities in primary care settings
Hudon et al.
cfp 2008;54:74-75.
ABSTRACT | FULL TEXT  

Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Chou et al.
ANN INTERN MED 2007;147:478-491.
ABSTRACT | FULL TEXT  

Meta-analysis: Acupuncture for Osteoarthritis of the Knee
Manheimer et al.
ANN INTERN MED 2007;146:868-877.
ABSTRACT | FULL TEXT  

A 60-Year-Old Woman Considering Acupuncture for Knee Pain
Berman
JAMA 2007;297:1697-1707.
ABSTRACT | FULL TEXT  

Postoperative ibuprofen increased bleeding complications in hospital and did not improve pain or physical function at 6-12 months after total hip replacement
Closs
Evid. Based Nurs. 2007;10:57-57.
FULL TEXT  

An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Ong et al.
Clin Med Res 2007;5:19-34.
ABSTRACT | FULL TEXT  

Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study
Rahme et al.
Rheumatology (Oxford) 2007;46:265-272.
ABSTRACT | FULL TEXT  

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
Lanas et al.
Gut 2006;55:1731-1738.
ABSTRACT | FULL TEXT  

Spironolactone and risk of upper gastrointestinal events: population based case-control study
Verhamme et al.
BMJ 2006;333:330.
ABSTRACT | FULL TEXT  

NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland
Helin-Salmivaara et al.
Eur Heart J 2006;27:1657-1663.
ABSTRACT | FULL TEXT  

Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada
Rahme et al.
Rheumatology (Oxford) 2006;45:903-910.
ABSTRACT | FULL TEXT  

Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?
Elliott et al.
Rheumatology (Oxford) 2006;45:606-613.
ABSTRACT | FULL TEXT  

Evaluation of the quality of prognosis studies in systematic reviews.
Hayden et al.
ANN INTERN MED 2006;144:427-437.
ABSTRACT | FULL TEXT  

Are Cyclooxygenase-2 Inhibitors Being Taken Only by Those Who Need Them?
Kaufman et al.
Arch Intern Med 2005;165:1066-1067.
FULL TEXT  

Taking stock of coxibs
DTB 2005;43:1-6.
ABSTRACT | FULL TEXT  

Nonsteroidal Antiinflammatory Drug Use Among Patients with GI Bleeding
Dominick et al.
The Annals of Pharmacotherapy 2004;38:1159-1164.
ABSTRACT | FULL TEXT  

For Discussion NSAIDs: gastroprotection or selective COX-2 inhibitor?
Dickman and Ellershaw
Palliat Med 2004;18:275-286.
ABSTRACT  

Aging Biology and Geriatric Clinical Pharmacology
McLean and Le Couteur
Pharmacol. Rev. 2004;56:163-184.
ABSTRACT | FULL TEXT  

Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs
Garcia Rodriguez and Hernandez-Diaz
Am J Epidemiol 2004;159:23-31.
ABSTRACT | FULL TEXT  

Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention
Podichetty et al.
Postgrad. Med. J. 2003;79:627-633.
ABSTRACT | FULL TEXT  

Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation: Physicians' Fears Often Unfounded
Man-Son-Hing and Laupacis
Arch Intern Med 2003;163:1580-1586.
ABSTRACT | FULL TEXT  

Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs
Traversa et al.
BMJ 2003;327:18-22.
ABSTRACT | FULL TEXT  

Linking Laboratory and Pharmacy: Opportunities for Reducing Errors and Improving Care
Schiff et al.
Arch Intern Med 2003;163:893-900.
ABSTRACT | FULL TEXT  

Economic Impact of Pharmacists' Interventions with Nonsteroidal Antiinflammatory Drugs
Guignard et al.
The Annals of Pharmacotherapy 2003;37:332-338.
ABSTRACT | FULL TEXT  

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs
Mamdani et al.
BMJ 2002;325:624-624.
ABSTRACT | FULL TEXT  

Paracetamol toxicity: epidemiology, prevention and costs to the health-care system
SHEEN et al.
QJM 2002;95:609-619.
ABSTRACT | FULL TEXT  

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs
Hawkey et al.
Gut 2002;51:336-343.
ABSTRACT | FULL TEXT  

Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users
Hawkey et al.
Gut 2002;51:344-350.
ABSTRACT | FULL TEXT  

Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation
Man-Son-Hing and Laupacis
Arch Intern Med 2002;162:541-550.
ABSTRACT | FULL TEXT  

Management of gastrointestinal haemorrhage
Ghosh et al.
Postgrad. Med. J. 2002;78:4-14.
ABSTRACT | FULL TEXT  

Steroids and Risk of Upper Gastrointestinal Complications
Hernandez-Diaz and Rodriguez
Am J Epidemiol 2001;153:1089-1093.
ABSTRACT | FULL TEXT  

Preventing Recurrent Upper Gastrointestinal Bleeding in Patients with Helicobacter pylori Infection Who Are Taking Low-Dose Aspirin or Naproxen
Chan et al.
NEJM 2001;344:967-973.
ABSTRACT | FULL TEXT  

Summing Up the Risk for NSAID-Associated UGI Complications
JWatch Gastroenterology 2000;2000:1-1.
FULL TEXT